Eton Pharmaceuticals (ETON) Payables (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Payables of $11.0 million for Q4 2025, down 23.02% sequentially from $14.3 million in Q3 2025, and up 163.4% YoY from $4.2 million in Q4 2024.
Eton Pharmaceuticals (ETON) Payables (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Payables for 9 years, with the latest figure at $11.0 million in Q4 2025.
- Quarterly Payables rose 163.4% year-over-year to $11.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.0 million (up 163.4% YoY) and the FY2025 annual result came in at $11.0 million, up 163.4% from the prior year.
- Payables slipped to $11.0 million in Q4 2025 per ETON's latest filing, from $14.3 million in the prior quarter.
- Over five years, Payables peaked at $14.3 million in Q3 2025 and troughed at $1.1 million in Q3 2022.
- A 5-year average of $3.8 million and a median of $2.1 million in 2022 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2025: Payables plunged 67.8% in 2022, then soared 469.25% in 2025.
- Over 5 years, Payables stood at $1.8 million in 2021, then slipped by 0.45% to $1.8 million in 2022, then climbed by 4.64% to $1.8 million in 2023, then surged by 125.49% to $4.2 million in 2024, then surged by 163.4% to $11.0 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $11.0 million, $14.3 million, and $12.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 986.00 Mn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.41 Mn |
| Dec 31, 2025 | 10.98 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 12.14 Mn |
| Mar 31, 2025 | 4.87 Mn |
| Dec 31, 2024 | 4.17 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 2.13 Mn |
| Mar 31, 2024 | 2.26 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 2.30 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 2.13 Mn |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | 3.27 Mn |
| Jun 30, 2021 | 1.52 Mn |